Printer Friendly

Australia : Dr. Jayantha Wijayabandara received US Patent for a New Drug for type II Diabetes.

US patent has been obtained by Dr. Jayantha Wijayabandara, former coordinator and Senior Lecturer of the B. Pharm Degree Program, Faculty of Medical Sciences, for a novel pharmacological property of ? Amyrin Acetate derived from Tabernaemontana dichotoma (Sinhala Divi Kaduru) as a potent ? glucosidase inhibitor.

This discovery also provides for the use of this compound as a novel oral hypoglycemic drug in the treatment of type II diabetes being approximately 35 times potent compared with Acarbose, a standard drug widely prescribed to type II diabetes patients. Non insulin dependent diabetes (NIDDM) or type II diabetes is expending at an alarming rate around the world for a multitude of reasons. Alpha glucosidase inhibitors are suggested to be valuable aids in the treatment of diabetes. They act by delaying the digestion and absorption of carbohydrates, thereby lowering postprandial blood glucose levels.

Dr. Wijayabandara and his research team at the International Center for Chemical and Biological Sciences (H. E. J. Research Institute of Chemistry and Dr. Panjwani Center for Molecular Medicine and Drug Research), University of Karachi, Pakistan are now working to explore commercialization of this invention through developing this molecule into a pharmaceutically elegant dosage form.

Dr. Wijayabandaras achievement has brought prestige not only to the University of Sri Jayewardenepura but also to Sri Lanka as a whole. And also, his achievement will give an encouragement towards the advancement of academic research in the University system in Sri Lanka.

He would like to acknowledge Former President Mr. Mahinda Rajapaksha and Mr. Lalith Weeratunga, Former Secretary to the President for releasing funds from the Presidents fund for obtaining this patent.

[c] 2017 Al Bawaba ( Provided by SyndiGate Media Inc. ( ).

COPYRIGHT 2017 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Date:May 24, 2017
Previous Article:Australia : Dilrukshi Wins 1st Place at the 29th Japanese Speech Contest 2017.
Next Article:Canada : Parents reasons for not vaccinating children influence public attitudes toward them.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters